Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erlinge

Showing results (441-450 of 458) with videos related to

Pageof 46
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
JAMA|November 9, 2025
Coronary Computed Tomography Angiography in Prediction of First Coronary EventsGöran Bergström, Gunnar Engström, Elias Björnson, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
European Heart Journal|November 15, 2024
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)Chris Wilkinson, Asad Bhatty, Gorav Batra, et al.
Vaccine|November 4, 2023
Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trialZubair Akhtar, Matthias Götberg, David Erlinge, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 9, 2024
Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measures: european Unified Registries for heart Care evaluation and randomised trials (EuroHeart)Asad Bhatty, Chris Wilkinson, Gorav Batra, et al.
American Heart Journal|October 24, 2022
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trialOle Fröbert, Matthias Götberg, David Erlinge, et al.
The New England Journal of Medicine|November 19, 2013
Targeted temperature management at 33°C versus 36°C after cardiac arrestNiklas Nielsen, Jørn Wetterslev, Tobias Cronberg, et al.
Circulation|August 30, 2021
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialOle Fröbert, Matthias Götberg, David Erlinge, et al.
Pageof 46

Showing results (441-450 of 458) with videos related to

Sort By:
Pageof 46
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomesMaddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
JAMA|November 9, 2025
Coronary Computed Tomography Angiography in Prediction of First Coronary EventsGöran Bergström, Gunnar Engström, Elias Björnson, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
European Heart Journal|November 15, 2024
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)Chris Wilkinson, Asad Bhatty, Gorav Batra, et al.
Vaccine|November 4, 2023
Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trialZubair Akhtar, Matthias Götberg, David Erlinge, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 9, 2024
Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measures: european Unified Registries for heart Care evaluation and randomised trials (EuroHeart)Asad Bhatty, Chris Wilkinson, Gorav Batra, et al.
American Heart Journal|October 24, 2022
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trialOle Fröbert, Matthias Götberg, David Erlinge, et al.
The New England Journal of Medicine|November 19, 2013
Targeted temperature management at 33°C versus 36°C after cardiac arrestNiklas Nielsen, Jørn Wetterslev, Tobias Cronberg, et al.
Circulation|August 30, 2021
Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialOle Fröbert, Matthias Götberg, David Erlinge, et al.
Pageof 46